A detailed history of Gradient Investments LLC transactions in Amgen Inc stock. As of the latest transaction made, Gradient Investments LLC holds 57,036 shares of AMGN stock, worth $17.6 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
57,036
Previous 62,378 8.56%
Holding current value
$17.6 Million
Previous $18 Million 9.74%
% of portfolio
0.46%
Previous 0.5%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$268.87 - $324.56 $1.44 Million - $1.73 Million
-5,342 Reduced 8.56%
57,036 $16.2 Million
Q4 2023

Jan 18, 2024

SELL
$255.7 - $288.46 $797,784 - $899,995
-3,120 Reduced 4.76%
62,378 $18 Million
Q3 2023

Oct 27, 2023

BUY
$218.65 - $271.46 $13.2 Million - $16.4 Million
60,587 Added 1233.7%
65,498 $17.6 Million
Q2 2023

Jul 11, 2023

BUY
$214.27 - $253.37 $6,642 - $7,854
31 Added 0.64%
4,911 $1.09 Million
Q1 2023

Apr 17, 2023

SELL
$225.79 - $275.2 $225 - $275
-1 Reduced 0.02%
4,880 $1.18 Million
Q4 2022

Jan 10, 2023

BUY
$229.03 - $291.01 $1,374 - $1,746
6 Added 0.12%
4,881 $0
Q3 2022

Oct 14, 2022

BUY
$224.46 - $253.15 $160,488 - $181,002
715 Added 17.19%
4,875 $1.1 Million
Q2 2022

Jul 11, 2022

SELL
$230.71 - $256.74 $13.7 Million - $15.3 Million
-59,537 Reduced 93.47%
4,160 $1.01 Million
Q1 2022

May 26, 2022

BUY
$219.27 - $242.57 $389,204 - $430,561
1,775 Added 2.87%
63,697 $15.4 Million
Q4 2021

Jan 12, 2022

BUY
$198.88 - $227.6 $1.21 Million - $1.38 Million
6,084 Added 10.9%
61,922 $13.9 Million
Q3 2021

Oct 18, 2021

BUY
$212.27 - $248.7 $1.24 Million - $1.46 Million
5,862 Added 11.73%
55,838 $11.9 Million
Q2 2021

Jul 12, 2021

BUY
$233.58 - $259.14 $805,150 - $893,255
3,447 Added 7.41%
49,976 $12.2 Million
Q1 2021

Apr 21, 2021

BUY
$221.91 - $258.6 $906,280 - $1.06 Million
4,084 Added 9.62%
46,529 $11.6 Million
Q4 2020

Jan 08, 2021

SELL
$216.38 - $257.67 $126,365 - $150,479
-584 Reduced 1.36%
42,445 $10.8 Million
Q3 2020

Oct 06, 2020

SELL
$234.65 - $260.95 $76,495 - $85,069
-326 Reduced 0.75%
43,029 $10.9 Million
Q2 2020

Jul 10, 2020

SELL
$197.81 - $242.74 $821,504 - $1.01 Million
-4,153 Reduced 8.74%
43,355 $10.2 Million
Q1 2020

Apr 07, 2020

BUY
$182.24 - $241.7 $54,307 - $72,026
298 Added 0.63%
47,508 $9.63 Million
Q4 2019

Jan 15, 2020

SELL
$189.21 - $243.2 $319,954 - $411,251
-1,691 Reduced 3.46%
47,210 $11.4 Million
Q3 2019

Oct 10, 2019

BUY
$174.11 - $208.62 $7.87 Million - $9.43 Million
45,183 Added 1215.25%
48,901 $9.46 Million
Q2 2019

Jul 16, 2019

BUY
$166.7 - $195.41 $24,171 - $28,334
145 Added 4.06%
3,718 $685,000
Q1 2019

Apr 11, 2019

BUY
$180.87 - $203.88 $2,893 - $3,262
16 Added 0.45%
3,573 $679,000
Q4 2018

Jan 18, 2019

BUY
$178.4 - $208.25 $12,844 - $14,994
72 Added 2.07%
3,557 $692,000
Q3 2018

Oct 11, 2018

SELL
$185.29 - $208.89 $43,357 - $48,880
-234 Reduced 6.29%
3,485 $722,000
Q2 2018

Aug 09, 2018

BUY
$166.05 - $186.51 $35,866 - $40,286
216 Added 6.17%
3,719 $686,000
Q1 2018

Apr 11, 2018

SELL
$169.43 - $198.0 $2,033 - $2,376
-12 Reduced 0.34%
3,503 $597,000
Q4 2017

Feb 07, 2018

SELL
$168.79 - $188.59 $140,264 - $156,718
-831 Reduced 19.12%
3,515 $611,000
Q3 2017

Oct 16, 2017

BUY
$167.29 - $191.0 $727,042 - $830,086
4,346
4,346 $810,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $165B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gradient Investments LLC Portfolio

Follow Gradient Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.